JBIO
Jade Biosciences, Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$806.82M
P/E Ratio
—
EPS
$-3.19
Beta
—
52W High
$97.54
52W Low
$6.57
50-Day MA
$14.61
200-Day MA
$11.42
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Jade Biosciences, Inc.
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is headquartered in Waltham, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-113.52M |
| Operating Margin | 0.00% |
| Return on Equity | -89.20% |
| Return on Assets | -33.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.74 |
| Price-to-Book | 2.30 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $49.32M |
| Float | $32.43M |
| % Insiders | 1.36% |
| % Institutions | 101.98% |
Analyst Ratings
Consensus ($28.71 target)
9
BuyData last updated: 4/8/2026